The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

The cytokine IL-6 acts via a specific receptor complex that consists of the membrane-bound IL-6 receptor (mIL-6R) or the soluble IL-6 receptor (sIL-6R) and glycoprotein 130 (gp130). In this study, we investigated the role of IL-6R components in asthma. We observed increased levels of sIL-6R in the airways of patients with allergic asthma as compared to those in controls. In addition, local blockade of the sIL-6R in a murine model of late-phase asthma after OVA sensitization by gp130-fraction constant led to suppression of Th2 cells in the lung. By contrast, blockade of mIL-6R induced local expansion of Foxp3-positive CD4+CD25+ Tregs with increased immunosuppressive capacities. CD4+CD25+ but not CD4+CD25- lung T cells selectively expressed the IL-6R alpha chain and showed IL-6-dependent STAT-3 phosphorylation. Finally, in an in vivo transfer model of asthma in immunodeficient Rag1 mice, CD4+CD25+ T cells isolated from anti-IL-6R antibody-treated mice exhibited marked immunosuppressive and antiinflammatory functions. IL-6 signaling therefore controls the balance between effector cells and Tregs in the lung by means of different receptor components. Furthermore, inhibition of IL-6 signaling emerges as a novel molecular approach for the treatment of allergic asthma.

[1]  G. Berry,et al.  Induction of T helper type 1–like regulatory cells that express Foxp3 and protect against airway hyper-reactivity , 2004, Nature Immunology.

[2]  Peter R. Galle,et al.  Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7 , 2004, The Journal of Immunology.

[3]  Markus F Neurath,et al.  IL-6 trans-signaling: the heat is on. , 2004, Immunity.

[4]  Donald Metcalf,et al.  SOCS3 negatively regulates IL-6 signaling in vivo , 2003, Nature Immunology.

[5]  J. Johnston,et al.  Matching SOCS with function , 2003, Nature Immunology.

[6]  M. Brenner,et al.  IL-6 Production by Pulmonary Dendritic Cells Impedes Th1 Immune Responses 1 , 2003, The Journal of Immunology.

[7]  F. Ramsdell,et al.  An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.

[8]  A. O’Garra,et al.  Twenty-first century Foxp3 , 2003, Nature Immunology.

[9]  D. Umetsu,et al.  Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity , 2003, Nature Medicine.

[10]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[11]  N. Krug,et al.  Local release of eosinophil peroxidase following segmental allergen provocation in asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  F. Powrie,et al.  Regulating the Regulators , 2003, Science.

[13]  Ruslan Medzhitov,et al.  Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.

[14]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[15]  Xinmin Cao,et al.  Protein Kinase C δ Associates with the Interleukin-6 Receptor Subunit Glycoprotein (gp) 130 via Stat3 and Enhances Stat3-gp130 Interaction* , 2002, The Journal of Biological Chemistry.

[16]  Y. Belkaid,et al.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.

[17]  R. Price,et al.  Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. , 2002, Arthritis and rheumatism.

[18]  K. Kallen.  The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. , 2002, Biochimica et biophysica acta.

[19]  G. Berry,et al.  Antigen-specific regulatory T cells develop via the ICOS–ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity , 2002, Nature Medicine.

[20]  E. Serfling,et al.  Induction of NFATc2 Expression by Interleukin 6 Promotes T Helper Type 2 Differentiation , 2002, The Journal of experimental medicine.

[21]  M. Neurath,et al.  The role of Th1/Th2 polarization in mucosal immunity , 2002, Nature Medicine.

[22]  T. Naka,et al.  The paradigm of IL-6: from basic science to medicine , 2002, Arthritis research.

[23]  S. Szabo,et al.  Development of Spontaneous Airway Changes Consistent with Human Asthma in Mice Lacking T-bet , 2002, Science.

[24]  R. Flavell,et al.  Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. , 2002, The Journal of clinical investigation.

[25]  F. Powrie,et al.  Regulatory T cells in the control of immune pathology , 2001, Nature Immunology.

[26]  L. Dekker,et al.  Sequential Activation of Rac-1, SEK-1/MKK-4, and Protein Kinase Cδ Is Required for Interleukin-6-induced STAT3 Ser-727 Phosphorylation and Transactivation* , 2001, The Journal of Biological Chemistry.

[27]  N. Krug,et al.  Cytokine Profile of Bronchoalveolar Lavage–Derived CD4+, CD8+, and γδ T Cells in People with Asthma after Segmental Allergen Challenge , 2001 .

[28]  M. Neurath,et al.  Treatment of Allergic Airway Inflammation and Hyperresponsiveness by Antisense-Induced Local Blockade of Gata-3 Expression , 2001, The Journal of experimental medicine.

[29]  T. S. Wilkinson,et al.  Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. , 2001, Immunity.

[30]  K. Garcia,et al.  Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex , 2001, Science.

[31]  Simon A. Jones,et al.  The soluble interleukin 6 receptor: mechanisms of production and implications in disease , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  R. Atreya.  IL-6 trans-signaling mediates T cell resistance against apoptosis in Crohn's disease , 2000 .

[33]  S. Holgate.  The epidemic of allergy and asthma , 1999, Nature.

[34]  D. H. Zhang,et al.  Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. , 1999, Immunity.

[35]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[36]  S. Rose-John,et al.  Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. , 1998, Blood.

[37]  E. Chi,et al.  Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. , 1997, The Journal of clinical investigation.

[38]  S. Akira,et al.  IL-6-regulated transcription factors. , 1997, The international journal of biochemistry & cell biology.

[39]  N. Kohno,et al.  Circulating levels of soluble interleukin-6 receptor in patients with bronchial asthma. , 1997, American journal of respiratory and critical care medicine.

[40]  P. Marrack,et al.  IL-6 rescues resting mouse T cells from apoptosis. , 1997, Journal of immunology.

[41]  J. Drazen,et al.  T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice , 1997, Nature Medicine.

[42]  E. Walters,et al.  IL-5 production by bronchoalveolar lavage and peripheral blood mononuclear cells in asthma and atopy. , 1997, The European respiratory journal.

[43]  G. Ciliberto,et al.  Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. , 1997, Immunity.

[44]  E. Fikrig,et al.  Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T Cells , 1997, The Journal of experimental medicine.

[45]  T. Hirano,et al.  Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. , 1996, Immunity.

[46]  S. Akira,et al.  STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  E. Lander,et al.  Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice , 1995, Nature Genetics.

[48]  P. Heinrich,et al.  Soluble receptors for cytokines and growth factors: generation and biological function. , 1994, The Biochemical journal.

[49]  N. Woychik,et al.  Regulating the regulators. , 1994, Trends in biochemical sciences.

[50]  N. Udagawa,et al.  Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  S. Durham,et al.  T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. , 1993, American journal of respiratory cell and molecular biology.

[52]  S. Durham,et al.  Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. , 1993, The Journal of allergy and clinical immunology.

[53]  D. Broide,et al.  Cytokines in symptomatic asthma airways. , 1992, The Journal of allergy and clinical immunology.

[54]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[55]  Partridge,et al.  International Consensus Report on Diagnosis and Treatment of Asthma. , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.